Source: Υπουργείο Υγείας (CY) Revision Year: 2013 Publisher: Codal Synto Ltd, 33 Theklas Lysioti Street, 3030 Limassol, Cyprus
Syntoclor 250 mg capsules.
Syntoclor 500 mg capsules.
| Pharmaceutical Form |
|---|
|
Lilac-ivory hard capsule. For oral administration. |
Each capsule contains either 250mg or 500mg of cefaclor.
Excipient with known effect: azorubine.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Cefaclor |
Cefaclor is a second-generation cephalosporin antibiotic. Cefaclor has no activity against Pseudomonas species or Acinetobacter species. Methicillin-resistant staphylococci and most strains of enterococci (eg, Str. faecalis) are resistant to cefaclor. |
| List of Excipients |
|---|
|
The capsules also contain sodium starch glycolate, magnesium stearate, gelatin, titanium dioxide (E171), azorubine (E122) and indigo carmine(E132). |
Capsules are in combination blisters of aluminium foil and polyvinylchloride film.
Cartons of 16, 100, 500 or 1000 capsules, with a patient information leaflet, are available.
Not all pack sizes may be marketed.
Codal Synto Ltd, 33 Theklas Lysioti Street, 3030 Limassol, Cyprus
Syntoclor 250mg capsules: 20005
Syntoclor 500mg capsules: 20018
Syntoclor 250mg capsules: 29/12/2005
Syntoclor 500mg capsules: 29/12/2005
| Drug | Countries | |
|---|---|---|
| SYNTOCLOR | Cyprus, Hong Kong |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
